These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 9146616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
    Epstein JI, Walsh PC, Carmichael M, Brendler CB.
    JAMA; 1994 Feb 02; 271(5):368-74. PubMed ID: 7506797
    [Abstract] [Full Text] [Related]

  • 3. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS, Cookson MS, Coffey CS, Vader V, Roberts RL, Chang SS, Smith JA, Shappell SB.
    J Urol; 2002 Aug 02; 168(2):519-24. PubMed ID: 12131301
    [Abstract] [Full Text] [Related]

  • 4. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings.
    Epstein JI, Chan DW, Sokoll LJ, Walsh PC, Cox JL, Rittenhouse H, Wolfert R, Carter HB.
    J Urol; 1998 Dec 02; 160(6 Pt 2):2407-11. PubMed ID: 9817393
    [Abstract] [Full Text] [Related]

  • 5. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
    Epstein JI, Walsh PC, Brendler CB.
    J Urol; 1994 Nov 02; 152(5 Pt 2):1721-9. PubMed ID: 7523719
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M, Stamey TA, McNeal JE, Yemoto CM.
    J Urol; 2001 Jul 02; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [Abstract] [Full Text] [Related]

  • 8. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H.
    J Urol; 2000 Jan 02; 163(1):174-8. PubMed ID: 10604340
    [Abstract] [Full Text] [Related]

  • 9. Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis.
    Partin AW, Criley SR, Subong EN, Zincke H, Walsh PC, Oesterling JE.
    J Urol; 1996 Apr 02; 155(4):1336-9. PubMed ID: 8632568
    [Abstract] [Full Text] [Related]

  • 10. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease.
    Miyake H, Sakai I, Harada K, Hara I, Eto H.
    Int J Urol; 2005 Mar 02; 12(3):270-4. PubMed ID: 15828954
    [Abstract] [Full Text] [Related]

  • 11. Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population?
    Anast JW, Andriole GL, Bismar TA, Yan Y, Humphrey PA.
    Urology; 2004 Sep 02; 64(3):544-50. PubMed ID: 15351590
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Minute focus of prostate cancer on needle biopsy: correlation with radical prostatectomy specimen.
    Montanari E, Del Nero A, Gazzano G, Mangiarotti B, Bernardini P, Longo F, Cordima G, Itri E.
    Arch Ital Urol Androl; 2009 Mar 02; 81(1):9-12. PubMed ID: 19499751
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.
    Makarov DV, Humphreys EB, Mangold LA, Walsh PC, Partin AW, Epstein JI, Freedland SJ.
    J Urol; 2006 Aug 02; 176(2):554-8. PubMed ID: 16813888
    [Abstract] [Full Text] [Related]

  • 16. Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial.
    Southwick PC, Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, Walsh PC, Scardino PT, Lange PH, Gasior GH, Parson RE, Loveland KG.
    J Urol; 1999 Oct 02; 162(4):1346-51. PubMed ID: 10492194
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.
    Gao X, Mohideen N, Flanigan RC, Waters WB, Wojcik EM, Leman CR.
    J Urol; 2000 Dec 02; 164(6):1982-6. PubMed ID: 11061896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.